Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Vascular Surgery · Peripheral Artery Disease

Procedures and Building Your Care Team

At a Glance

PAD procedures may be considered when walking pain remains disabling despite supervised exercise and medical treatment, or urgently when poor blood flow threatens a limb. Doctors weigh surgical risk, limb severity, artery anatomy, and personal goals when choosing catheter treatment or bypass.

For many patients with Peripheral Artery Disease (PAD), medications and exercise are enough to manage symptoms. However, when those treatments aren’t enough, or when the disease becomes severe, your doctor may consider revascularization—a procedure designed to restore blood flow to your legs [1][2].

When is a Procedure Considered?

Choosing to have a procedure is a shared decision that depends on your stage of PAD, your anatomy, and your personal goals:

  1. Lifestyle-Limiting Claudication: If your walking pain severely restricts your daily life, and you have given an adequate trial of supervised exercise and optimal medical therapy without acceptable improvement, you may consider a procedure [3][4].
  2. Chronic Limb-Threatening Ischemia (CLTI): If you have pain at rest, non-healing sores, or gangrene, you require urgent vascular evaluation. Revascularization is often necessary to help save the limb, but it is not feasible for everyone and must be integrated with wound care, infection management, and an assessment of your overall goals [2][5].
  3. Acute Limb Ischemia (ALI): As discussed in the warning signs page, a sudden loss of blood flow is an emergency requiring immediate intervention [6].

Two Approaches to Restoring Flow

There are two primary ways to open blocked arteries. Both approaches carry risks, including bleeding, arterial injury, contrast-related kidney complications, infection, and the need for repeat procedures [2][7].

1. Endovascular Therapy (The “Inside” Approach)

This is a minimally invasive technique where a doctor threads a thin tube called a catheter through your arteries.

  • How it works: The doctor uses a small balloon to stretch the artery open (angioplasty) or places a metal mesh tube called a stent to hold it open [4].
  • The Benefits: It requires only a tiny incision, has a lower risk of wound infections, and often allows for a faster initial recovery [8][9].
  • The Trade-off: Endovascular repairs can be less durable depending on the lesion length and location. A portion of patients may need a second procedure (reintervention) within two years because the artery narrows again (restenosis) [4][10].

2. Open Surgical Bypass (The “Detour” Approach)

This is a traditional surgery where a vascular surgeon creates a “detour” around the blocked segment of the artery.

  • How it works: The surgeon uses a piece of your own vein (ideally the great saphenous vein from your leg) or a synthetic tube to sew a new path for blood to flow [11][12].
  • The Benefits: Bypass surgery—especially when using your own vein—often provides more durable, long-term flow. For patients with CLTI who have a suitable great saphenous vein, trials like BEST-CLI have shown that bypass can lead to fewer major limb problems or deaths compared to endovascular treatment [11][10]. (This specific advantage does not necessarily apply to ordinary claudication or patients without a suitable vein).
  • The Trade-off: It is a larger operation requiring a hospital stay and carries a higher risk of short-term wound complications and perioperative risks [8][9].

Choosing Your Treatment Path: The PLAN

For severe cases like CLTI, specialists often use frameworks like PLAN, WIfI, and GLASS to help guide complex limb-salvage decisions:

  • Patient Risk: Can your heart and lungs tolerate a larger surgery? [2]
  • Limb Severity (WIfI): A score evaluating Wound extent, Ischemia (blood flow), and foot Infection [2][5].
  • ANatomic Complexity (GLASS): A grading system that looks at the exact locations of blockages to estimate success rates of different interventions [2][13].

Building Your Vascular Care Team

Because PAD is a systemic disease, you should ideally be treated by a multidisciplinary team. A comprehensive approach might include:

  • Integrated Specialists: Access to vascular specialists, podiatrists for foot care, wound care specialists, and cardiologists [14][15].
  • Advanced Imaging: The ability to perform high-quality Duplex Ultrasound, CTA, or MRA to map your arteries [13][16].
  • Long-Term Surveillance: A structured plan to check your pulses or perform ultrasounds after your procedure to catch any new blockages early [17][18].

Remember, a procedure is just one part of your journey. Even after successful revascularization, continuing your medications, foot care, and walking program is essential to keep your new “plumbing” open and your heart safe [19][20].

Common questions in this guide

When might I need a procedure for peripheral artery disease?
A procedure may be considered when walking pain substantially limits daily activities despite an adequate trial of supervised exercise and medical treatment. Rest pain, non-healing sores, gangrene, or a sudden loss of blood flow require urgent vascular evaluation; severe cases may need rapid treatment to protect the limb.
How do angioplasty and stenting differ from bypass surgery for PAD?
Angioplasty and stenting are catheter-based treatments that open a blockage from inside the artery through a small incision. Bypass surgery creates a new route around the blockage using a vein or synthetic tube, so it is a larger operation with more wound and short-term surgical risk. Catheter-based treatment often has a quicker initial recovery, while a vein bypass may provide more durable flow in selected severe cases.
Is bypass surgery more effective than a stent for severe PAD?
Neither option is best for everyone. For chronic limb-threatening ischemia, bypass may lead to fewer major limb problems or deaths than catheter-based treatment when a suitable great saphenous vein is available, but this advantage does not automatically apply to ordinary walking pain or people without a usable vein. Doctors also consider heart and lung health, artery anatomy, and personal goals.
How long do PAD stents last, and could I need another procedure?
Durability varies, especially with the length and location of the blockage. Some people need a repeat procedure within two years because the artery narrows again, a problem called restenosis. Follow-up visits and ultrasound surveillance can help detect recurrent narrowing early.
What specialists should be part of my PAD care team?
A coordinated team may include a vascular specialist or surgeon, podiatrist, wound-care specialist, and cardiologist. The team should also have access to artery imaging such as duplex ultrasound, CT angiography, or magnetic resonance angiography, plus a plan for long-term follow-up.
What information helps doctors choose between a PAD stent and bypass?
Doctors consider your heart and lung health, the severity of any wound, reduced blood flow or infection, the location and complexity of blockages, and your goals. The WIfI system summarizes wound, ischemia (reduced blood flow), and foot infection, while GLASS describes blockage anatomy to help estimate which approach may work best.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms and tests, are we considering procedures for lifestyle-limiting claudication or for chronic limb-threatening ischemia (CLTI)?
  2. 2.Do I have a suitable great saphenous vein that can be used if we decide on a bypass surgery?
  3. 3.What is my anatomic complexity, and how does it affect the success rate of a stent versus a bypass?
  4. 4.If we choose the endovascular (stent/balloon) route, what is the likelihood I will need a second procedure within the next two years?
  5. 5.Does this facility have access to a multidisciplinary 'limb-salvage' team that includes podiatry, wound care, and vascular surgery?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Current and emerging approaches to managing peripheral artery disease: a specialist review.

    Mohammadi A, Hussein L, Yahyavi A, Shishehbor MH

    Heart (British Cardiac Society) 2026; doi:10.1136/heartjnl-2025-326532.

    PMID: 41965269
  2. 2

    Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.

    Conte MS, Bradbury AW, Kolh P, et al.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2019; (58(1S)):S1-S109.e33 doi:10.1016/j.ejvs.2019.05.006.

    PMID: 31182334
  3. 3

    State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?

    Mosarla RC, Armstrong E, Bitton-Faiwiszewski Y, et al.

    Journal of the Society for Cardiovascular Angiography & Interventions 2022; (1(5)) doi:10.1016/j.jscai.2022.100439.

    PMID: 36268042
  4. 4

    Durability of Exercise vs. Revascularization in Intermittent Claudication: An Updated Meta-Analysis of Randomized Trials Focusing on Patient-Centered Outcomes.

    Puljevic M, Grubic-Rotkvic P, Dubravcic-Dosen M, et al.

    Healthcare (Basel, Switzerland) 2026; (14(2)) doi:10.3390/healthcare14020170.

    PMID: 41595306
  5. 5

    [Lower extremity arterial disease (LEAD)].

    Espinola-Klein C

    Herz 2024; (49(4)):313-318 doi:10.1007/s00059-024-05252-3.

    PMID: 38916707
  6. 6

    Acute Limb Ischemia Interventions.

    Ahmed A, Naeem N, Jain A, et al.

    Interventional cardiology clinics 2025; (14(2)):273-282 doi:10.1016/j.iccl.2024.11.012.

    PMID: 40049853
  7. 7

    Infra-inguinal bypass surgery vs endovascular revascularization for chronic limb-threatening ischemia in average- and high-risk patients.

    Morisaki K, Matsuda D, Guntani A, et al.

    Journal of vascular surgery 2024; (80(1)):204-212.e3 doi:10.1016/j.jvs.2024.03.025.

    PMID: 38522583
  8. 8

    Comparing the efficacy and safety of endovascular therapy versus surgical revascularization for critical limb-threatening ischemia: A systematic review and Meta-analysis.

    Abouzid MR, Vyas A, Kamel I, et al.

    Progress in cardiovascular diseases 2025; (88()):126-135 doi:10.1016/j.pcad.2024.06.008.

    PMID: 38981532
  9. 9

    A Propensity-Matched Analysis of Endovascular Intervention versus Open Nonautologous Bypass as Initial Therapy in Patients with Chronic Limb-Threatening Ischemia.

    Futchko J, Friedmann P, Phair J, et al.

    Annals of vascular surgery 2021; (75()):194-204 doi:10.1016/j.avsg.2021.02.024.

    PMID: 33819581
  10. 10

    Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.

    Giles KA, Farber A, Menard MT, et al.

    Journal of vascular surgery 2024; (80(5)):1515-1524 doi:10.1016/j.jvs.2024.05.049.

    PMID: 38908805
  11. 11

    Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.

    Farber A, Menard MT, Conte MS, et al.

    The New England journal of medicine 2022; (387(25)):2305-2316 doi:10.1056/NEJMoa2207899.

    PMID: 36342173
  12. 12

    A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.

    Almasri J, Adusumalli J, Asi N, et al.

    Journal of vascular surgery 2019; (69(6S)):126S-136S doi:10.1016/j.jvs.2018.01.071.

    PMID: 31159976
  13. 13

    A narrative review of imaging misallocation in peripheral artery disease: a value-based medicine perspective.

    Raskin D, Partovi S, Levitin A, et al.

    Cardiovascular diagnosis and therapy 2025; (15(6)):1194-1205 doi:10.21037/cdt-2025-426.

    PMID: 41509627
  14. 14

    Peripheral artery disease.

    Aboyans V, Canonico ME, Chastaingt L, et al.

    Nature reviews. Disease primers 2025; (11(1)):68 doi:10.1038/s41572-025-00651-0.

    PMID: 40968271
  15. 15

    The Role of Lower Extremity Amputation in Chronic Limb-Threatening Ischemia.

    Kim TI, Mena C, Sumpio BE

    The International journal of angiology : official publication of the International College of Angiology, Inc 2020; (29(3)):149-155 doi:10.1055/s-0040-1710075.

    PMID: 32904807
  16. 16

    Validation of the Global Limb Anatomic Staging System in first-time lower extremity revascularization.

    Liang P, Marcaccio CL, Darling JD, et al.

    Journal of vascular surgery 2021; (73(5)):1683-1691.e1 doi:10.1016/j.jvs.2020.08.151.

    PMID: 33091516
  17. 17

    Optimal conduit choice for open lower extremity bypass in chronic limb-threatening ischemia.

    Thomas JP, So KL, Turner JT, et al.

    Seminars in vascular surgery 2022; (35(2)):172-179 doi:10.1053/j.semvascsurg.2022.05.001.

    PMID: 35672107
  18. 18

    Endovascular intervention for peripheral artery disease.

    Thukkani AK, Kinlay S

    Circulation research 2015; (116(9)):1599-613 doi:10.1161/CIRCRESAHA.116.303503.

    PMID: 25908731
  19. 19

    Medical management of claudication.

    Ratchford EV

    Journal of vascular surgery 2017; (66(1)):275-280 doi:10.1016/j.jvs.2017.02.040.

    PMID: 28533077
  20. 20

    2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    , Gornik HL, Aronow HD, et al.

    Journal of the American College of Cardiology 2024; (83(24)):2497-2604 doi:10.1016/j.jacc.2024.02.013.

    PMID: 38752899

This page is for informational purposes only and does not constitute medical advice. A vascular specialist can help interpret your tests and discuss the safest treatment plan for your situation.

Get notified when new evidence is published on peripheral arterial disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.